avatar for Hillel Cohen

Hillel Cohen

Sandoz Inc.
Executive Director, Scientific Affairs
Hillel Cohen is Executive Director at Sandoz, helping explain policies to the healthcare community, patient advocacy groups, & health authorities. Current areas of focus include switching, substitution, interchangeability & safety. He led Sandoz efforts for the first biosimilar presentation (Zarxio®) to an FDA advisory committee and participated in BsUFA2 negotiations. Dr. Cohen is active in biosimilar trade associations, focusing on education. He received a BA from NYU and a PhD from Dartmouth.